Keyphrases
Parkinson's Disease
100%
Parkinson Patients
26%
Patients with Parkinson's Disease
20%
Ashkenazi Jews
17%
Leucine-rich Repeat Kinase 2 (LRRK2)
14%
Levodopa-induced Dyskinesia
13%
Familial Mediterranean Fever
10%
Botulinum Toxin Injection
10%
Age of Onset
10%
Levodopa
9%
Healthy Controls
8%
Israel
8%
Dyskinesia
7%
Motor Fluctuations
7%
Ethnic Groups
7%
Early-late
7%
Multiple Sclerosis
7%
Cerebrotendinous Xanthomatosis
7%
Jewish Patients
7%
HF-rTMS
7%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
7%
Unified Parkinson's Disease Rating Scale (UPDRS)
6%
Non-carriers
6%
LRRK2 G2019S mutation
6%
G2019S mutation
6%
Motor Symptoms
5%
Botulinum Neurotoxin (BoNT)
5%
Estimated Glomerular Filtration Rate
5%
Neuropsychological Tests
5%
Jewish
5%
Motor Diseases
5%
Mutation Status
5%
GBA mutations
5%
Medicine and Dentistry
Parkinson's Disease
38%
Symptom
9%
Botulinum Toxin
9%
Cerebrotendinous Xanthomatosis
7%
Spasmodic torticollis
7%
Ataxia
7%
Familial Mediterranean Fever
7%
Optic Nerve Atrophy
6%
Disease
6%
Onset Age
5%
Stereotypic Movement Disorder
5%